Pedro D. Santabarbara

Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

BlueWillow Biologics, Inc. develops biopharmaceutical products. It offers vaccines targeting respiratory, sexually transmitted, and intranasal immunotherapy for food and respiratory allergies. The company was founded by James R. Baker Jr. and is headquartered in Ann Arbor, MI.

Pervasis Therapeutics, Inc. is a clinical stage company developing a broad portfolio of biologically active therapeutics. The company was founded by Robert S. Langer Jr. and Helen Marie Nugent in 2004 and is headquartered in Waltham, MA.

Ulthera, Inc. provides ultrasound therapy under the Ultherapy brand. It focuses on ultrasound imaging to to deliver its collagen-boosting treatment. The company was founded by Peter G. Barthe, Inder Raj S. Makin, Brain D. Oconner, Lana Slayton, and Michael H. Slayto n in April 2004 and is headquartered in Raleigh, NC.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Monitor is an American private investment company.

Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools.

TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA.

Prospect Venture Partners (Prospect Venture Partners) is a venture capital firm founded in 1997 by Alexander E. Barkas and David Schnell. The firm is headquartered in Palo Alto, California.

Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA.

Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY.

Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY.

The American Philosophical Society is an organization that hosts biannual general meetings for its members, families, and distinguished guests. The non-profit company is based in Philadelphia, PA. The meetings cater to the diverse interests and expertise of attendees and provide a unique opportunity to indulge the audience’s breadth of intellectual curiosity. The society has an exceptional collection of over 13 million manuscripts, objects, books, images, and works of art covering various topics such as early and revolutionary history, natural history, Indian linguistics and culture, nuclear physics, computer development, medical science, genetics and eugenics, and the development of cultural anthropology.

Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina.

NeuroHealing Pharmaceuticals, Inc. develops drug therapies for the post-acute and chronic neuro-rehabilitation patients. Its products include NH001, a dopaminergic agent to help post traumatic brain injury patients to emerge from a coma, vegetative, or minimally consciousness state, NH004, a treatment for the social debilitating condition of sialorrhea, a non-motor complaint of Parkinson's disease patients and NH02D, an orally administered drug for on-demand treatment of premature ejaculation, a male sexual disorder affecting sexually active men. The company was founded by Esteban Fridman and Daniel Katzman in 2003 and is headquartered in Waban, MA.

Locust Walk Partners LLC provides commercial supporting and advisory services. The firm involves in securities-related transactions for clients, including mergers and acquisitions, private placements & mezzanine financings and partnerships involving equity investments. The company was founded by Geoff Meyerson and Joseph Mohr in 2008 and is headquartered in Boston, MA.

Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA.

Yingo Yango, Inc. operates a post-discharge patient engagement platform. It is a white-label mobile platform for care management and health and wellness program delivery. The company provides patients with post-discharge instructions, especially post-operative, is both content and paper. It serves employers, provider systems, and third-party administrators. Yingo Yango was founded by Marty Jaramillo in 2011 and is headquartered in Weatogue, CT.

Part of Roche Holding AG, Chugai Pharmabody Research Pte Ltd. is a pharmaceutical company based in Singapore, Singapore. The Singaporean company's mission is to create innovative drugs for the benefit of patients. Chugai Pharmabody specializes in intracellular protein-protein interactions (PPIs) and has successfully established a proprietary library of orally available and cell-permeable cyclic peptides and screening technology. The company's first mid-size molecule drug, Luna18, is a result of their advanced biotechnology and chemistry. The company's research units are crucial in antibody research and drug discovery, achieving high caliber practices.

Humatics Corp. manufactures micro location systems and develops analytical software. Its products allow engineers, scientists, designers, artists, filmmakers, factory workers and others to open up new vistas through the precise connection of the spatial and digital worlds. The company was founded by David A. Mindell and Gary Cohen in 2015 and is headquartered in Cambridge, MA.

Oppilan Pharma Ltd. operates as a biotechnology company. The company is headquartered in Cambridge, the United Kingdom.

Escalier Biosciences BV develops biological products. The company is headquartered in Nijmegen, the Netherlands.

Paige Ai, Inc. engages in revolutionizing pathology and strengthen lynchpin of medical diagnostics with quantitative, computational technology, fusing machine learning, and human expertise. It involves in building an artificial intelligence to change clinical diagnosis and treatment of cancer. The company is headquartered in New York, NY.

Memorial Sloan-Kettering Cancer Center (Investment Management) (MSK-IM) is the investment management division of Memorial Sloan-Kettering Cancer Center, a non-profit organization headquartered in New York City. The firm was formed in 1960 to coordinate and guide the overall policy for Memorial Hospital and the Sloan Kettering Institute, and in 1980 these entities were unified into a single institution, with a single president and CEO. MSK-IM manages the investment portfolio of MSK.

Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz.

LIPAC Oncology LLC engages in the provision of drug delivery services. It offers LiPax, a proliposomal intracavitary paclitaxel drug delivery platform. The company was founded by Ramachandran R. Thirucote, Willem A. Robberts and Michael Oefelein in 2016 and is headquartered in Pomona, CA.